119 related articles for article (PubMed ID: 7833092)
1. Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase.
Peters GJ; van der Wilt CL; van Groeningen CJ
Eur J Cancer; 1994; 30A(10):1408-11. PubMed ID: 7833092
[No Abstract] [Full Text] [Related]
2. [Dihydropyrimidine dehydrogenase and thymidylate synthase activities in colonic cancer tissue and sensitivity to 5-fluorouracil].
Araki S; Isomoto H; Matsumoto A; Kaihara J; Yasunaga M; Hayashi K; Yatsugi H; Yamauchi K
Nihon Geka Gakkai Zasshi; 1999 Dec; 100(12):822. PubMed ID: 10766580
[No Abstract] [Full Text] [Related]
3. Dual modulation of 5-fluorouracil cytotoxicity using folinic acid with a dihydropyrimidine dehydrogenase inhibitor.
Fischel JL; Formento P; Etienne MC; Spector T; Renée N; Milano G
Biochem Pharmacol; 1997 Jun; 53(11):1703-9. PubMed ID: 9264323
[TBL] [Abstract][Full Text] [Related]
4. A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil.
Beck A; Etienne MC; Chéradame S; Fischel JL; Formento P; Renée N; Milano G
Eur J Cancer; 1994; 30A(10):1517-22. PubMed ID: 7833111
[TBL] [Abstract][Full Text] [Related]
5. Dihydropyrimidine dehydrogenase, multidrug resistance-associated protein, and thymidylate synthase gene expression levels can predict 5-fluorouracil resistance in human gastrointestinal cancer cells.
Kirihara Y; Yamamoto W; Toge T; Nishiyama M
Int J Oncol; 1999 Mar; 14(3):551-6. PubMed ID: 10024690
[TBL] [Abstract][Full Text] [Related]
6. Roles of thymidylate synthase and dihydropyrimidine dehydrogenase in tumor progression and sensitivity to 5-fluorouracil in human gastric cancer.
Terashima M; Irinoda T; Fujiwara H; Nakaya T; Takagane A; Abe K; Yonezawa H; Oyama K; Inaba T; Saito K; Takechi T; Fukushima M
Anticancer Res; 2002; 22(2A):761-8. PubMed ID: 12014648
[TBL] [Abstract][Full Text] [Related]
7. Relationships between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase and cell proliferative activity and 5-fluorouracil sensitivity in colorectal carcinoma.
Fujii R; Seshimo A; Kameoka S
Int J Clin Oncol; 2003 Apr; 8(2):72-8. PubMed ID: 12720098
[TBL] [Abstract][Full Text] [Related]
8. Intratumoural thymidylate synthase and dihydropyrimidine dehydrogenase activities are good predictors of 5-fluorouracil sensitivity in colorectal cancer.
Ishibiki Y; Kitajima M; Sakamoto K; Tomiki Y; Sakamoto S; Kamano T
J Int Med Res; 2003; 31(3):181-7. PubMed ID: 12870370
[TBL] [Abstract][Full Text] [Related]
9. Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen.
Grem JL; Danenberg KD; Behan K; Parr A; Young L; Danenberg PV; Nguyen D; Drake J; Monks A; Allegra CJ
Clin Cancer Res; 2001 Apr; 7(4):999-1009. PubMed ID: 11309351
[TBL] [Abstract][Full Text] [Related]
10. Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5-fluorouracil in colorectal cancer.
Nita ME; Tominaga O; Nagawa H; Tsuruo T; Muto T
Hepatogastroenterology; 1998; 45(24):2117-22. PubMed ID: 9951876
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of 5-fluorouracil induced inhibition of thymidylate synthase in human colon tumors by leucovorin is dose dependent.
Peters GJ; Hoekman K; van Groeningen CJ; van der Wilt CL; Smid K; Meijer S; Pinedo HM
Adv Exp Med Biol; 1993; 338():613-6. PubMed ID: 8304192
[No Abstract] [Full Text] [Related]
12. Thymidylate synthase expression and activity: relation to S-phase parameters and 5-fluorouracil sensitivity.
Mirjolet JF; Barberi-Heyob M; Merlin JL; Marchal S; Etienne MC; Milano G; Bey P
Br J Cancer; 1998 Jul; 78(1):62-8. PubMed ID: 9662252
[TBL] [Abstract][Full Text] [Related]
13. Changes in thymidylate synthase and its inhibition rate and changes in dihydropyrimidine dehydrogenase after the administration of 5-fluorouracil with cisplatin to nude mice with gastric cancer xenograft SC-1-NU.
Sakurai Y; Uraguchi T; Imazu H; Hasegawa S; Matsubara T; Ochiai M; Funabiki T
Gastric Cancer; 2004; 7(2):110-6. PubMed ID: 15224198
[TBL] [Abstract][Full Text] [Related]
14. Leucovorin enhancement of the effects of the fluoropyrimidines on thymidylate synthase.
Morgan RG
Cancer; 1989 Mar; 63(6 Suppl):1008-12. PubMed ID: 2521810
[TBL] [Abstract][Full Text] [Related]
15. Tumor cell responses to inhibition of thymidylate synthase.
Moran RG; Keyomarsi K; Patel R
Adv Exp Med Biol; 1988; 244():71-83. PubMed ID: 2977717
[TBL] [Abstract][Full Text] [Related]
16. Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells.
Houghton JA; Morton CL; Adkins DA; Rahman A
Cancer Res; 1993 Sep; 53(18):4243-50. PubMed ID: 8364921
[TBL] [Abstract][Full Text] [Related]
17. High expression of thymidylate synthase leads to resistance to 5-fluorouracil in biliary tract carcinoma in vitro.
Habara K; Ajiki T; Kamigaki T; Nakamura T; Kuroda Y
Jpn J Cancer Res; 2001 Oct; 92(10):1127-32. PubMed ID: 11676864
[TBL] [Abstract][Full Text] [Related]
18. [Modulation of the biochemical effect of 5-fluorouracil (5-FU) by leucovorin measured by thymidylate synthase activity and nucleoside incorporation into DNA].
Kau B; Rieger M; Sauer H
Onkologie; 1990 Dec; 13(6):453-7. PubMed ID: 2092282
[TBL] [Abstract][Full Text] [Related]
19. Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase.
Banerjee D; Mayer-Kuckuk P; Capiaux G; Budak-Alpdogan T; Gorlick R; Bertino JR
Biochim Biophys Acta; 2002 Jul; 1587(2-3):164-73. PubMed ID: 12084458
[TBL] [Abstract][Full Text] [Related]
20. Selective protection by uridine of growth inhibition by 5-fluorouracil (5FU) mediated by 5FU incorporation into RNA, but not the thymidylate synthase mediated growth inhibition by 5FU-leucovorin.
Codacci-Pisanelli G; Noordhuis P; van der Wilt CL; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):733-9. PubMed ID: 18600533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
